|
- Portec Conveyor Systems and Parts | Flomaster Belt Curves
Whether you are looking for replacement parts for your current Portec system or looking to design a Portec conveyor system in your workplace, we are the experts!
- Adjuvant chemoradiotherapy versus radiotherapy alone for women with . . .
The PORTEC-3 trial was initiated to investigate the benefit of adjuvant chemotherapy during and after radiotherapy (chemoradiotherapy) versus pelvic radiotherapy alone for women with high-risk endometrial cancer
- Interroll Portec Specialty Conveyors
Airport Baggage and Parcel Handling The Interroll Portec Belt Curve can be found in airports throughout the world It is a hard-working, dependable piece of machinery loved by maintenance personnel because it requires very little attention The Interroll Portec Belt Curve helps maintain product spacing and orientation throughout the entire turn
- PORTEC-4a at ESTRO 2025: International randomised trial of molecular . . .
Vienna, Austria — A major international clinical trial, PORTEC-4a, has demonstrated that molecular profiling can safely reduce the use of radiotherapy for women with early-stage endometrial cancer, while identifying those who may benefit from more intensive treatment
- Stage I Endometrial Cancer Calculator - Bayta
This software is designed to take clinical and pathologic risk factor inputs for Stage I endometrial cancer
- Is the PORTEC 4a trial exploring too little and too late?
In the PORTEC 4a study,1 the authors evaluate adjuvant external beam radiation and vaginal brachytherapy in stage I and II endometrial cancer However, the molecular classification of endometrial cancer has changed the paradigm of treatment across the stages
- PORTEC 3: Adjuvant chemotherapy vs. radiotherapy in high-risk . . .
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial
- Molecular Profiling May Optimize Treatment for Endometrial Cancer
A major international study, PORTEC-4a, provides evidence that molecular profiling may safely reduce the need for radiotherapy in some women with early-stage endometrial cancer while identifying those who would benefit from more intensive treatment
|
|
|